Roth MD - Search Results

1

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Liau LM, et al. Among authors: roth md. Clin Cancer Res. 2005 Aug 1;11(15):5515-25. doi: 10.1158/1078-0432.CCR-05-0464. Clin Cancer Res. 2005. PMID: 16061868 Clinical Trial.

2

Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.

Roth MD, Cheng Q, Harui A, Basak SK, Mitani K, Low TA, Kiertscher SM. Roth MD, et al. J Immunol. 2002 Oct 15;169(8):4651-6. doi: 10.4049/jimmunol.169.8.4651. J Immunol. 2002. PMID: 12370405

3

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells.

Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. Yuan M, et al. Among authors: roth md. J Neuroimmunol. 2002 Dec;133(1-2):124-31. doi: 10.1016/s0165-5728(02)00370-3. J Neuroimmunol. 2002. PMID: 12446015

4

Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancer.

Gitlitz BJ, Figlin RA, Kiertscher SM, Moldawer N, Rosen F, Roth MD. Gitlitz BJ, et al. Among authors: roth md. J Immunother. 2003 Mar-Apr;26(2):171-8. doi: 10.1097/00002371-200303000-00010. J Immunother. 2003. PMID: 12616109 Clinical Trial.

5

Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.

Kiertscher SM, Gitlitz BJ, Figlin RA, Roth MD. Kiertscher SM, et al. Among authors: roth md. Int J Cancer. 2003 Nov 1;107(2):256-61. doi: 10.1002/ijc.11379. Int J Cancer. 2003. PMID: 12949803 Clinical Trial.

6

Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.

Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM. Mao JT, et al. Among authors: roth md. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5835-41. Clin Cancer Res. 2003. PMID: 14676104

7

Modifying adenoviral vectors for use as gene-based cancer vaccines.

Basak SK, Kiertscher SM, Harui A, Roth MD. Basak SK, et al. Among authors: roth md. Viral Immunol. 2004;17(2):182-96. doi: 10.1089/0882824041310603. Viral Immunol. 2004. PMID: 15279698 Review.

8

Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.

Mao JT, Tsu IH, Dubinett SM, Adams B, Sarafian T, Baratelli F, Roth MD, Serio KJ. Mao JT, et al. Among authors: roth md. Clin Cancer Res. 2004 Oct 15;10(20):6872-8. doi: 10.1158/1078-0432.CCR-04-0945. Clin Cancer Res. 2004. PMID: 15501964 Clinical Trial.

9

Celecoxib decreases Ki-67 proliferative index in active smokers.

Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin DP, Dubinett SM. Mao JT, et al. Among authors: roth md. Clin Cancer Res. 2006 Jan 1;12(1):314-20. doi: 10.1158/1078-0432.CCR-05-1440. Clin Cancer Res. 2006. PMID: 16397057 Clinical Trial.

10

Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells.

Sarafian T, Montes C, Harui A, Beedanagari SR, Kiertscher S, Stripecke R, Hossepian D, Kitchen C, Kern R, Belperio J, Roth MD. Sarafian T, et al. Among authors: roth md. Toxicol Appl Pharmacol. 2008 Sep 15;231(3):282-90. doi: 10.1016/j.taap.2008.05.001. Epub 2008 May 9. Toxicol Appl Pharmacol. 2008. PMID: 18556036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters